3.0.0 2500 2024-10-03T20:18:53Z 2024-10-03T20:18:53Z House H HR 2023-04-06 118 [Congressional Record Volume 169, Number 60 (Thursday, April 6, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. KIM of New Jersey:H.R. 2500.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the United States ConstitutionThe single subject of this legislation is:Health[Page H1710]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-04-14T17:51:18Z Referred to 2023-04-06T15:00:35Z Protecting PAHPA Act of 2023 118 4697 HR 2023-07-21 Referred to the Subcommittee on Health. Related bill CRS 2023-04-14 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-04-06 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-04-06 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-04-06 Introduced in House IntroReferral 1000 9 Library of Congress K000394 Rep. Kim, Andy [D-NJ-3] Andy Kim D NJ 3 N S001168 Rep. Sarbanes, John P. [D-MD-3] John Sarbanes D MD P. 3 2023-06-15 False Health Health 2024-10-03T20:18:53Z 00 2023-04-06 Introduced in House 2023-11-15T16:54:57Z Protecting Americans from Unsafe Drugs Act of 2023

This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs.

Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)

]]> Protecting Americans from Unsafe Drugs Act of 2023 Display Title 45 Protecting Americans from Unsafe Drugs Act of 2023 2024-07-24T15:22:57Z Short Title(s) as Introduced 101 Protecting Americans from Unsafe Drugs Act of 2023 2024-05-24T13:41:11Z Introduced in House IH Official Title as Introduced 6 To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes. 2024-03-18T20:35:53Z Introduced in House IH Introduced in House 2023-04-06T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr2500ih/xml/BILLS-118hr2500ih.xml 2023-04-14 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.